Simultaneous Delivery of Electrostatically Complexed Multiple Gene-Targeting siRNAs and an Anticancer Drug for Synergistically Enhanced Treatment of Prostate Cancer

Molecular Pharmaceutics
Eunshil ChoiSehoon Kim

Abstract

Simultaneous silencing of multiple apoptosis-related genes is an attractive approach to treat cancer. In this article, we present a multiple gene-targeting siRNA/drug delivery system for prostate cancer treatment with a high efficiency. Bcl-2, survivin, and androgen receptor genes involved in the cell apoptosis pathways were chosen as silencing targets with three different siRNAs. The colloidal nanocomplex delivery system (<10 nm in size) was formulated electrostatically between anionic siRNAs and a cationic drug (BZT), followed by encapsulation with the Pluronic F-68 polymer. The formulated nanocomplex system exhibited sufficient stability against nuclease-induced degradation, leading to successful intracellular delivery for the desired therapeutic performance. Silencing of targeted genes and apoptosis induction were evaluated in vitro on human prostate LNCaP-LN3 cancer cells by using various biological analysis tools (e.g., real-time PCR, MTT cell viability test, and flow cytometry). It was demonstrated that when the total loaded siRNA amounts were kept the same in the nanocomplexes, the simultaneous silencing of triple genes with co-loaded siRNAs (i.e., Bcl-2, survivin, and AR-targeting siRNAs) enhanced BZT-induced apoptosis...Continue Reading

References

Feb 9, 1999·Vitamins and Hormones·A K RoyB Chatterjee
Feb 17, 1999·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Y Tsujimoto
Mar 22, 2001·Advanced Drug Delivery Reviews·R K Jain
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Apr 12, 2002·The Prostate·Kevin R McElenyJohn M Fitzpatrick
Jun 5, 2002·Nature Reviews. Cancer·Samuel R Denmeade, John T Isaacs
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
Oct 22, 2003·Molecular Genetics and Metabolism·Jerry C ChengKathleen M Sakamoto
Apr 15, 2004·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
Mar 1, 2005·Oncogene·Min ZhangArnab Chakravarti
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·S Moein MoghimiAdam Szewczyk
Jun 21, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Joanna RejmanMassimo Conese
Jul 14, 2005·Journal of Neurochemistry·Thuy-Vi V NguyenChristian J Pike
Jul 13, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongtao LvJie Yan
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenneth W YipFei-Fei Liu
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Feb 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dirk Grimm, Mark A Kay
Apr 29, 2008·Nature Biotechnology·Akin AkincDaniel G Anderson
Jan 23, 2009·Nature·Daniela Castanotto, John J Rossi
Jan 31, 2009·Nature Reviews. Drug Discovery·Kathryn A WhiteheadDaniel G Anderson
Apr 18, 2009·Toxicology and Applied Pharmacology·Anastasia MalekAchim Aigner
May 9, 2009·Advanced Drug Delivery Reviews·Yu-Kyoung Oh, Tae Gwan Park
Sep 1, 2009·Journal of the American Chemical Society·William DobbsLaurent Douce
Dec 17, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dries VercauterenKevin Braeckmans
Jun 15, 2010·The AAPS Journal·Jie WangJessie L-S Au
Dec 25, 2010·Biomaterials·Soo Hyeon LeeTae Gwan Park
Mar 5, 2011·Small·Shawn J TanDan Luo
Apr 19, 2011·Nature Reviews. Genetics·Beverly L Davidson, Paul B McCray
Oct 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kevin BuyensNiek N Sanders
Jul 17, 2012·International Journal of Oncology·Doreen KunzeSusanne Fuessel
Mar 30, 2013·Cellular Logistics·Dipannita Dutta, Julie G Donaldson
Oct 26, 2013·Nanomedicine·Orapan PaecharoenchaiRobert J Lee
May 17, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eunjung LeeSehoon Kim
Aug 27, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·So Jin LeeKwangmeyung Kim

❮ Previous
Next ❯

Citations

Dec 9, 2020·Cancers·Amirhossein Bahreyni, Honglin Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.